Hao C - Search Results

1

Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.

Zhang H, Xie X, Zhu X, Zhu J, Hao C, Lu Q, Ding L, Liu Y, Zhou L, Liu Y, Huang C, Wen C, Ye Q. Zhang H, et al. Among authors: hao c. J Biol Chem. 2005 Dec 30;280(52):43188-97. doi: 10.1074/jbc.M506598200. Epub 2005 Oct 11. J Biol Chem. 2005. PMID: 16219765 Free article.

2

[Effects of exogenous ER beta expression on the cell growth properties of MCF-7 breast cancer cell line].

Zhu JH, Ye QN, Song ST, Jiang ZF, Yan JH, Hao CF, Huang CF. Zhu JH, et al. Zhonghua Zhong Liu Za Zhi. 2006 Feb;28(2):103-6. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16750012 Chinese.

3

The effects of RKIP gene expression on the biological characteristics of human triple-negative breast cancer cells in vitro.

Hao C, Wei S, Tong Z, Li S, Shi Y, Wang X, Zhu ZH. Hao C, et al. Tumour Biol. 2012 Aug;33(4):1159-67. doi: 10.1007/s13277-012-0358-7. Epub 2012 Feb 29. Tumour Biol. 2012. PMID: 22373584

4

Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer.

Jia Y, Song Y, Dong G, Hao C, Zhao W, Li S, Tong Z. Jia Y, et al. Among authors: hao c. Sci Rep. 2019 Sep 10;9(1):12939. doi: 10.1038/s41598-019-49373-w. Sci Rep. 2019. PMID: 31506496 Free PMC article.

5

ILK promotes cell proliferation in breast cancer cells by activating the PI3K/Akt pathway.

Qu Y, Hao C, Xu J, Cheng Z, Wang W, Liu H. Qu Y, et al. Among authors: hao c. Mol Med Rep. 2017 Oct;16(4):5036-5042. doi: 10.3892/mmr.2017.7180. Epub 2017 Aug 7. Mol Med Rep. 2017. PMID: 28791358

6

[Relation of dose intensity and efficacy, toxicity in paclitaxel as a single agent for advanced breast cancer].

Liu F, Jiang ZF, Song ST, Liu XQ, Wang T, Yan M, Zhang SH, Hao CF, Sun JZ, Shen G. Liu F, et al. Zhonghua Zhong Liu Za Zhi. 2005 Jan;27(1):56-8. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 15771802 Chinese.

7

[Docetaxel and capecitabine combination chemotherapy for patients with anthracycline-resistant metastatic breast cancer].

Li SF, Wang X, Wang C, He LH, Shi YH, Hao CF, Dong GL, Tong ZS. Li SF, et al. Among authors: hao cf. Zhonghua Zhong Liu Za Zhi. 2008 Dec;30(12):944-6. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19174000 Chinese.

8

The changes of subtype markers between first and second primary breast cancers.

Li C, Lyu Z, Wang Z, Hao C, Huang Y, Song F. Li C, et al. Among authors: hao c. Cancer Med. 2023 Jun;12(12):13649-13660. doi: 10.1002/cam4.5979. Epub 2023 Apr 25. Cancer Med. 2023. PMID: 37096879 Free PMC article.

9

[Prognostic analysis of patients with metastatic triple-negative breast cancer: a report of 120 cases].

Miao PT, Tong ZS, Hao CF, Zhang L. Miao PT, et al. Zhonghua Yi Xue Za Zhi. 2010 Nov 2;90(40):2848-51. Zhonghua Yi Xue Za Zhi. 2010. PMID: 21162797 Chinese.

10

Expert consensus on the clinical application of immunotherapy in breast cancer: 2024.

Wang K, Yang J, Wang B, Liu Q, Wang X, Yin Y, Wang H, Wang S, Hao C, Hao X, Liu Y, Jiang Z; Chinese Society of Clinical Oncology Breast Cancer Committee*; Chinese Society of Clinical Oncology Breast Cancer Committee. Wang K, et al. Among authors: hao x, hao c. Transl Breast Cancer Res. 2024 Apr 29;5:9. doi: 10.21037/tbcr-24-15. eCollection 2024. Transl Breast Cancer Res. 2024. PMID: 38751677 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,804 results

Search Page

Filters